Law360, New York (January 09, 2009, 12:00 AM ET) -- The commonwealth of Pennsylvania has asked a federal judge to return a lawsuit to state court that accuses Merck & Co. of fraudulently representing its drug Vioxx and prompting the state to pay more than it would have for safer medications.
In a motion filed Thursday in the U.S. District Court for the Eastern District of Pennsylvania, the state rebuffed Merck's removal of the litigation to federal court. Pennsylvania maintains that Merck cannot meet the burden of proof to show there is a basis for federal...
Pa. Presses To Wage Vioxx Battle On State Turf
To view the full article, take a free trial now.
